Characterization of antibody subclasses and ADCC activity in RV305 extended, RV306, and RV328 clinical trial subjects
Research Grant
Administered By
Duke Human Vaccine Institute
Awarded By
Henry M. Jackson Foundation
Start Date
May 1, 2015
End Date
December 31, 2018
Administered By
Duke Human Vaccine Institute
Awarded By
Henry M. Jackson Foundation
Start Date
May 1, 2015
End Date
December 31, 2018